{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T05:36:32Z","timestamp":1777095392471,"version":"3.51.4"},"reference-count":33,"publisher":"The Japan Society of Coloproctology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Anus Rectum Colon"],"published-print":{"date-parts":[[2026,4,25]]},"DOI":"10.23922\/jarc.2025-118","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T22:11:58Z","timestamp":1777068718000},"page":"278-288","source":"Crossref","is-referenced-by-count":0,"title":["Preoperative and Pathological Discrepancies in Colorectal Cancer: A Single-Institution Retrospective Analysis Based on Mismatch Repair\/<i>BRAF<\/i> V600E Status"],"prefix":"10.23922","volume":"10","author":[{"given":"Yoshinori","family":"Iwata","sequence":"first","affiliation":[{"name":"Department of Surgery, Gifu Prefectural General Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihiro","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Surgery, Gifu Prefectural General Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Ohno","sequence":"additional","affiliation":[{"name":"Department of Surgery, Gifu Prefectural General Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunya","family":"Kiriyama","sequence":"additional","affiliation":[{"name":"Department of Surgery, Gifu Prefectural General Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kakeru","family":"Tawada","sequence":"additional","affiliation":[{"name":"Department of Surgery, Gifu Prefectural General Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonari","family":"Suetsugu","sequence":"additional","affiliation":[{"name":"Department of Surgery, Gifu Prefectural General Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Komori","sequence":"additional","affiliation":[{"name":"Department of Surgery, Gifu Prefectural General Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narutoshi","family":"Nagao","sequence":"additional","affiliation":[{"name":"Department of Surgery, Gifu Prefectural General Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Katayama","sequence":"additional","affiliation":[{"name":"Department of Pathology, Gifu Prefectural General Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Kawai","sequence":"additional","affiliation":[{"name":"Department of Surgery, Gifu Prefectural General Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10009","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229-263.","DOI":"10.3322\/caac.21834"},{"key":"2","unstructured":"2. Guinney J, Dienstmann R, Wang X, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015 Nov;21 (11):1350-6."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Yokota T, Ura T, Shibata N, et al. BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer. Br J Cancer. 2011 Mar;104 (5):856-62.","DOI":"10.1038\/bjc.2011.19"},{"key":"4","unstructured":"4. Nagasaka T, Kambara T, Tanaka N, et al. Clinicopathological and molecular analyses of synchronous colorectal cancers. Am J Pathol. 2007 Feb;170 (2):404-14."},{"key":"5","unstructured":"5. Loughrey MB, Arends MJ, Aaltonen LA, et al. Developing a comprehensive classification system for colorectal cancer. Virchows Arch. 2017 Aug;471 (2):255-63."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Sepulveda AR, Hamilton SR, Allegra CJ, et al. Molecular biomarkers for the evaluation of colorectal cancer: guideline from ASCP, CAP, AMP, and ASCO. J Clin Oncol. 2017 May;35 (13):1453-86.","DOI":"10.1200\/JCO.2016.71.9807"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Li GM. Mechanisms and functions of DNA mismatch repair. Cell Res. 2008 Jan;18 (1):85-98.","DOI":"10.1038\/cr.2007.115"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Iwata Y, Tanaka C, Ohno S, et al. Real-world outcomes of stage II and III colorectal cancers treated by postoperative adjuvant chemotherapy based on the mismatch repair status. Surg Today. 2025 Apr;55 (4):492-501.","DOI":"10.1007\/s00595-024-02932-9"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Fari\u00f1a-Sarasqueta A, van Lijnschoten G, Moerland E, et al. BRAF V600E mutation is an independent prognostic factor for survival in stage II and III colon cancer patients. Ann Oncol. 2010 Dec;21 (12):2396-402.","DOI":"10.1093\/annonc\/mdq258"},{"key":"10","unstructured":"10. Sepp\u00e4l\u00e4 TT, B\u00f6hm JP, Friman M, et al. BRAF V600E-mutated and microsatellite stable colorectal cancer: a population-based study. J Natl Cancer Inst. 2015 Jul;107 (7):djv272."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Yaeger R, Cercek A, Chou JF, et al. BRAF mutation predicts for poor outcomes after metastasectomy in patients with metastatic colorectal cancer. Cancer. 2014 Aug;120 (15):2316-24.","DOI":"10.1002\/cncr.28729"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Dienstmann R, Vermeulen L, Guinney J, et al. Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer. Nat Rev Cancer. 2017 Feb;17 (2):79-92.","DOI":"10.1038\/nrc.2016.126"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Andr\u00e9 T, Shiu KK, Kim TW, et al. Pembrolizumab in microsatellite-instability-high advanced colorectal cancer. N Engl J Med. 2020 Dec;383 (23):2207-18.","DOI":"10.1056\/NEJMoa2017699"},{"key":"14","unstructured":"14. Japanese Society for Cancer of the Colon and Rectum. Japanese guidelines for the treatment of colorectal cancer 2023. Tokyo: Igaku-Shoin; 2023."},{"key":"15","unstructured":"15. Benson AB, Venook AP, Al-Hawary MM, et al. NCCN Guidelines Insights: Colorectal Cancer Screening, Version 1.2024. J Natl Compr Canc Netw. 2024 May;22 (5):438-46."},{"key":"16","unstructured":"16. Van Cutsem E, Cervantes A, Adam R, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016 Aug;27 (8):1386-422."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Japanese Society for Cancer of the Colon and Rectum. Japanese classification of colorectal, appendiceal, and anal carcinoma: the 3rd English edition. J Anus Rectum Colon. 2019 Oct;3 (4):175-95.","DOI":"10.23922\/jarc.2019-018"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Brown G, Richards CJ, Newcombe RG, et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology. 2003;227:371-377.","DOI":"10.1148\/radiol.2272011747"},{"key":"19","unstructured":"19. Lahaye MJ, Engelen SM, Nelemans PJ, et al. Imaging for predicting the risk factors-the circumferential resection margin and nodal disease-of local recurrence in rectal cancer: a meta-analysis. Radiology. 2005;235:775-786."},{"key":"20","unstructured":"20. Tamandl D, Herberger B, Schmid R, et al. Imaging-based lymph node staging in colon cancer: correlation of CT and histopathologic findings. Eur J Radiol. 2011 Feb;80 (2):e231-5."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Sinicrope FA, Sargent DJ, Smyrk TC, et al. Clinical implications of microsatellite instability in sporadic colon cancers. Curr Opin Oncol. 2009 Jul;21 (4):369-73.","DOI":"10.1097\/CCO.0b013e32832c94bd"},{"key":"22","unstructured":"22. Overman MJ, Kopetz S, McDermott RS, et al. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer. J Clin Oncol. 2017 Mar;35 (8):773-9."},{"key":"23","unstructured":"23. Kim CG, Ahn JB, Jung M, et al. Mismatch repair deficiency is associated with response to immune checkpoint blockade in patients with metastatic colorectal cancer. Clin Cancer Res. 2022 Jan;28 (1):99-110."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Sargent DJ, Marsoni S, Monges G, et al. Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol. 2010 Jul;28 (20):3219-26.","DOI":"10.1200\/JCO.2009.27.1825"},{"key":"25","unstructured":"25. Nitsche U, Maak M, Schuster T, et al. Prediction of lymph node metastases in colon cancer using computed tomography: a prospective study. Int J Colorectal Dis. 2012 Apr;27 (4):467-74."},{"key":"26","unstructured":"26. Lahaye MJ, Engelen SM, Nelemans PJ, et al. Imaging for predicting the risk of lymph node metastases in rectal cancer: a systematic review. Radiology. 2005 Mar;234 (3):751-62."},{"key":"27","unstructured":"27. Sj\u00f6vall A, Blomqvist L, Egenvall M, et al. Tumor and nodal staging of colon cancer: accuracy of preoperative computed tomography. BMC Cancer. 2019 Dec;19 (1):1234."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Kawazoe K, Nakanishi R, Ando K, et al. Preoperative CT lymph node size as a predictor of nodal metastasis in resectable colon cancer: a retrospective study of 694 patients. BMC Gastroenterol. 2025 Jan;25 (1):18.","DOI":"10.1186\/s12876-025-03602-x"},{"key":"29","unstructured":"29. Ahn SJ, Park SH, Kim ST, et al. Radiomics analysis of contrast-enhanced CT predicts microsatellite instability in colorectal cancer. Eur Radiol. 2020 Oct;30 (10):5282-90."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Wan JCM, Massie C, Garcia-Corbacho J, et al. Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat Rev Cancer. 2017 Apr;17 (4):223-38.","DOI":"10.1038\/nrc.2017.7"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Siravegna G, Marsoni S, Siena S, et al. Integrating liquid biopsies into the management of cancer. Nat Rev Clin Oncol. 2017 Sep;14 (9):531-8.","DOI":"10.1038\/nrclinonc.2017.14"},{"key":"32","unstructured":"32. Nakamura Y, Taniguchi H, Ikeda M, et al. Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies. Nat Med. 2020 Dec;26 (12):1859-64."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Venook AP, Niedzwiecki D, Lenz HJ, et al. Impact of primary (right vs left) tumor location on overall survival in patients with metastatic colorectal cancer: analysis of CALGB\/SWOG 80405. J Clin Oncol. 2017 Oct;35 (28):2750-6.","DOI":"10.1200\/JCO.2017.35.15_suppl.3503"}],"container-title":["Journal of the Anus, Rectum and Colon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jarc\/10\/2\/10_2025-118\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T04:46:24Z","timestamp":1777092384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jarc\/10\/2\/10_2025-118\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.23922\/jarc.2025-118","relation":{},"ISSN":["2432-3853"],"issn-type":[{"value":"2432-3853","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"article-number":"2025-118"}}